Q2 EPS Estimates for Cardinal Health Cut by Leerink Partnrs

Cardinal Health, Inc. (NYSE:CAH) – Equities researchers at Leerink Partnrs reduced their Q2 2025 EPS estimates for shares of Cardinal Health in a research report issued on Friday, November 1st. Leerink Partnrs analyst M. Cherny now anticipates that the company will earn $1.82 per share for the quarter, down from their prior forecast of $1.83. The consensus estimate for Cardinal Health’s current full-year earnings is $7.69 per share. Leerink Partnrs also issued estimates for Cardinal Health’s Q4 2025 earnings at $1.98 EPS, FY2025 earnings at $7.87 EPS, FY2026 earnings at $8.85 EPS, FY2027 earnings at $9.65 EPS and FY2028 earnings at $10.56 EPS.

Cardinal Health (NYSE:CAH) last released its quarterly earnings data on Friday, November 1st. The company reported $1.88 EPS for the quarter, topping the consensus estimate of $1.62 by $0.26. The company had revenue of $52.28 billion during the quarter, compared to the consensus estimate of $50.90 billion. Cardinal Health had a net margin of 0.56% and a negative return on equity of 56.56%. Cardinal Health’s revenue for the quarter was down 4.3% on a year-over-year basis. During the same period last year, the firm earned $1.73 EPS.

Several other research analysts also recently commented on the stock. Argus raised their price target on shares of Cardinal Health from $115.00 to $125.00 and gave the company a “buy” rating in a report on Wednesday, September 11th. JPMorgan Chase & Co. raised their price target on shares of Cardinal Health from $111.00 to $123.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Robert W. Baird raised their price target on shares of Cardinal Health from $130.00 to $137.00 and gave the company an “outperform” rating in a report on Thursday, August 15th. Mizuho lifted their price objective on shares of Cardinal Health from $110.00 to $120.00 and gave the stock a “neutral” rating in a report on Monday. Finally, Wells Fargo & Company lifted their price objective on shares of Cardinal Health from $95.00 to $101.00 and gave the stock an “underweight” rating in a report on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have given a buy rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $123.00.

Cardinal Health Price Performance

Shares of NYSE:CAH opened at $113.18 on Monday. The firm has a fifty day moving average price of $111.79 and a two-hundred day moving average price of $104.20. Cardinal Health has a one year low of $93.17 and a one year high of $119.13. The company has a market cap of $27.39 billion, a price-to-earnings ratio of 22.02, a PEG ratio of 1.57 and a beta of 0.60.

Hedge Funds Weigh In On Cardinal Health

Several institutional investors have recently bought and sold shares of CAH. Allspring Global Investments Holdings LLC lifted its position in Cardinal Health by 379.5% during the first quarter. Allspring Global Investments Holdings LLC now owns 106,105 shares of the company’s stock valued at $11,873,000 after purchasing an additional 83,975 shares during the last quarter. Van ECK Associates Corp lifted its holdings in shares of Cardinal Health by 21.7% in the 1st quarter. Van ECK Associates Corp now owns 27,656 shares of the company’s stock worth $3,095,000 after acquiring an additional 4,938 shares during the last quarter. Private Advisor Group LLC lifted its holdings in shares of Cardinal Health by 13.4% in the 1st quarter. Private Advisor Group LLC now owns 12,077 shares of the company’s stock worth $1,350,000 after acquiring an additional 1,428 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. lifted its holdings in shares of Cardinal Health by 34.2% in the 1st quarter. Mirae Asset Global Investments Co. Ltd. now owns 85,580 shares of the company’s stock worth $9,576,000 after acquiring an additional 21,801 shares during the last quarter. Finally, Fidelis Capital Partners LLC bought a new stake in shares of Cardinal Health in the 1st quarter worth about $159,000. Institutional investors own 87.17% of the company’s stock.

Insider Buying and Selling at Cardinal Health

In other Cardinal Health news, insider Jessica L. Mayer sold 17,896 shares of the company’s stock in a transaction that occurred on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the completion of the sale, the insider now directly owns 94,529 shares of the company’s stock, valued at approximately $10,065,447.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other news, insider Jessica L. Mayer sold 17,896 shares of the stock in a transaction on Thursday, August 15th. The shares were sold at an average price of $106.48, for a total value of $1,905,566.08. Following the completion of the sale, the insider now directly owns 94,529 shares of the company’s stock, valued at $10,065,447.92. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Jessica L. Mayer sold 16,573 shares of the company’s stock in a transaction on Wednesday, August 21st. The stock was sold at an average price of $109.39, for a total transaction of $1,812,920.47. Following the transaction, the insider now owns 75,971 shares of the company’s stock, valued at approximately $8,310,467.69. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 113,963 shares of company stock valued at $12,379,980. Insiders own 0.09% of the company’s stock.

Cardinal Health Cuts Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Shareholders of record on Thursday, January 2nd will be issued a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.79%. Cardinal Health’s dividend payout ratio is currently 39.30%.

Cardinal Health Company Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.